Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

Resverlogix Corp. today announced that SUSTAIN, a Phase 2b clinical trial comprised of 176 subjects, is fully enrolled.

28 Nov 2011

Peter and Melanie Munk Charitable Foundation donates $18M to UHN cardiac centre

Dr. Robert Bell, President and CEO of University Health Network (UHN), announced today that the Peter and Melanie Munk Charitable Foundation is donating $18 million to the Peter Munk Cardiac Centre at UHN. This new gift brings the total investment by Peter and Melanie Munk in UHN to $65 million.

24 Nov 2011

Harmful BPA found in canned foods

According to a new study canned foods may contain harmful chemical Bisphenol A or BPA. BPA is a common chemical used in plastic products and in the lining of cans. BPA keeps them from corroding, but it may also be creeping into the food.

24 Nov 2011

Benefits of vitamin D-fortified yoghurt drink for people with diabetes

People with diabetes are known to have an increased risk of heart disease. New research published in BioMed Central's open access journal BMC Medicine shows that regular consumption of a vitamin D-fortified yoghurt drink improves cholesterol levels and biomarkers of endothelial dysfunction, a precursor of heart disease, in diabetics.

24 Nov 2011

Urban legend warns about dangers of snow shoveling

Urban legend warns shoveling snow causes heart attacks, and the legend seems all too accurate, especially for male wintery excavators with a family history of premature cardiovascular disease. However, until recently this warning was based on anecdotal reports.

24 Nov 2011

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet.

24 Nov 2011

BUSM professor receives 2011 ACN Communication Media Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.

23 Nov 2011

Imaging is about finding the most appropriate way to assess heart disease

"The idea is that we're using the most appropriate technology to address individual clinical questions rather than just focusing on one technique," explains EAE President Dr Luigi Badano, from the University of Padua, Italy.

23 Nov 2011

J-shaped relationship between wine intake and reduced cardiovascular risk

Research published in the European Journal of Epidemiology by Costanzo S, Di Castelnuovo de Gaetano G et al has sought to separate the effects of wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events. The Italian authors carried out an updated meta-analysis on the relationship between wine, beer or spirit consumption and cardiovascular outcomes, using state-of-the-art statistical techniques.

23 Nov 2011

Moderate salt intake may lower risk of cardiovascular events

For years doctors have warned that too much salt is bad for your heart. Now a new McMaster University study suggests that both high and low levels of salt intake may put people with heart disease or diabetes at increased risk of cardiovascular complications.

23 Nov 2011

Post-surgery death risk high among thinner people: Study

A new study has found that thinner people are at a higher risk of dying within 30 days of an operation than heavier people. The cause behind this trend is not clear.

22 Nov 2011

Non-alcoholic fatty liver disease does not appear to affect survival

Non-alcoholic fatty liver disease (NAFLD) is a common condition associated with obesity and heart disease long thought to undermine health and longevity. But a new study by Johns Hopkins researchers suggests the condition does not affect survival.

22 Nov 2011

CRF to sponsor Women's Heart Health Summit

The Cardiovascular Research Foundation (CRF) will sponsor the Women's Heart Health Summit: "In Pursuit of Excellence: Improving Cardiovascular Outcomes in Women." The goal of the meeting is to examine current prevention, treatment, and key research issues to collectively identify opportunities and recommendations that will lead to improved cardiovascular outcomes in women.

22 Nov 2011

EU's FP7 programme provides €6M grant for Thyroid Hormone Replacement for Subclinical Hypo-Thyroidism Trial

Dr Patricia Kearney, Department of Epidemiology & Public Health, UCC is one of a group of researchers from European Universities who will participate in a new research project investigating current treatment practices for people who suffer from a mildly underactive thyroid gland.

21 Nov 2011

Roundup: Fla. Medicare HMO closed; Tufts and BCBS resume talks

Quality Health Plans, a Medicare HMO with 10,000 Florida members, has been ordered into liquidation after failing to come up with the cash reserves the state says were needed. Its members will be moved to another -- still unnamed -- plan by Dec. 1.

19 Nov 2011

FDA assigns new PDUFA date for Takeda's investigational type 2 diabetes therapy, alogliptin

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., today announced that the company received notification from the U.S. Food and Drug Administration (FDA) that its review of investigational type 2 diabetes therapy alogliptin, and thus the fixed-dose combination therapy alogliptin/pioglitazone, will be delayed.

18 Nov 2011

AHA honors Gladstone scientist with Katz award for cardiovascular research

Li Qian, PhD, has won the Louis N. and Arnold M. Katz Basic Science Research Prize for Young Investigators from the American Heart Association (AHA), marking the first time in the prestigious award's history that a Gladstone Institutes researcher has been the recipient.

18 Nov 2011

Vitamin D and its good and bad effects on the heart

Vitamin D in excess may not be beneficial and may even harm the heart says a new study. Scientists have long known that low levels of the nutrient can hurt the heart, but new research shows that higher than normal levels can make it beat too fast and out of rhythm, a condition called atrial fibrillation. The study was presented at the annual meeting of the American Heart Association.

17 Nov 2011

Tripling clopidogrel dosage improves platelet reactivity in cardiac patients

Among patients with stable cardiovascular disease who have a genetic variation that diminishes the response to the antiplatelet drug clopidogrel, tripling the standard daily dosage of this medication resulted in improved platelet reactivity, according to a study appearing in JAMA.

17 Nov 2011

Sedentary behaviour may have different consequences for young people's health

Physical activity will definitely lower children's chances of developing cardiovascular disease down the road, but physical inactivity will not necessarily increase it. Findings from a recent Queen's University study shows different kinds of sedentary behaviour may have different consequences for young people's health.

17 Nov 2011